Move to Improve Physical Activity in Parkinson’s Disease

Move to Improve Physical Activity in Parkinson’s Disease

Publication date: Aug 09, 2019

Apathy is a multi-dimensional behavior characterized by impairments to motivation, planning and initiation; collectively called, goal-directed behavior. It is highly prevalent in patients suffering from neurological disorders such as Alzheimer’s disease and Parkinson’s disease (PD) as well as psychiatric disorders such as depression and schizophrenia. In PD, specifically, apathy is one of the more troublesome symptoms. Apathetic PD patients have greater disability, lower adherence to treatment plans and caregivers report greater stress and burden. Interventions grounded in behavioral economic theories, namely, financial and social incentives often promote positive behavioral change such as weight loss and smoking cessation. However, the effectiveness of these interventions varies across and within conditions and incentive type. It also tends to dissipate when incentives are no longer provided. To date, these approaches have not been used to promote behavior change in PD or other neurological conditions where apathetic behaviors are a pressing problem. The overall goal of this study is to test if behavioral economic approaches will reduce apathy, and subsequently, improve goal-directed behavior in Parkinson’s disease.

Concepts Keywords
Alzheimer Screen positive dementia
Apathy Consent Dementia
Behavior Change Disease
Behavioral Economic Psychology
Bluetooth Psychiatry
Cognition Human behavior
Decisional Capacity Psychiatric diagnosis
Dementia Cognitive disorders
Depression Learning disabilities
Disability Aging-associated diseases
Fitbit RTT
MCI Apathy
Mild Cognitive Impairment Dementia
Neurological Behavior change
Neurological Disorders Bluetooth
Parkinson Smartphones
Pennsylvania Smart phone
Psychiatric Disorders
Schizophrenia
Smart Phone
Smartphones
Smoking Cessation
Stress
Weight Loss

Semantics

Type Source Name
disease MESH Apathy
disease MESH multi
disease MESH suffering
disease MESH neurological disorders
disease MESH depression
disease MESH schizophrenia
disease DOID schizophrenia
disease MESH weight loss
disease MESH diagnosis
disease MESH mild cognitive impairment
gene UNIPROT MCIDAS
gene UNIPROT PTPN5
disease MESH dementia
disease DOID dementia
gene UNIPROT DOCK3
disease MESH Parkinson Disease
disease DOID Parkinson Disease

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *